Search Results - "D'Alessandro, Anthony M."

Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States – A Randomized Controlled Trial by Chapman, William C., Barbas, Andrew S., D’Alessandro, Anthony M., Vianna, Rodrigo, Kubal, Chandrashekhar A., Abt, Peter, Sonnenday, Christopher, Barth, Rolf, Alvarez-Casas, Josue, Yersiz, Hasan, Eckhoff, Devin, Cannon, Robert, Genyk, Yuri, Sher, Linda, Singer, Andrew, Feng, Sandy, Roll, Garrett, Cohen, Ari, Doyle, Maria B., Sudan, Debra L., Al-Adra, David, Khan, Adeel, Subramanian, Vijay, Abraham, Nader, Olthoff, Kim, Tekin, Akin, Berg, Lynn, Coussios, Constantin, Morris, Chris, Randle, Lucy, Friend, Peter, Knechtle, Stuart J.

“…A randomized controlled clinical trial comparison of conventional low temperature storage of transplant donor livers (static cold storage, SCS) with storage of…”
Get full text

The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single‐center analysis by Zens, Tiffany J., Danobeitia, Juan S., Leverson, Glen, Chlebeck, Peter J., Zitur, Laura J., Redfield, Robert R., D'Alessandro, Anthony M., Odorico, Scott, Kaufman, Dixon B., Fernandez, Luis A.

“…Introduction Renal transplant outcomes result from a combination of factors. Traditionally, donor factors were summarized by classifying kidneys as extended…”
Get full text

Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation by Danobeitia, Juan S., Zens, Tiffany J., Chlebeck, Peter J., Zitur, Laura J., Reyes, Jose A., Eerhart, Michael J., Coonen, Jennifer, Capuano, Saverio, D’Alessandro, Anthony M., Torrealba, Jose R., Burguete, Daniel, Brunner, Kevin, Van Amersfoort, Edwin, Ponstein, Yolanda, Van Kooten, Cees, Jankowska‐Gan, Ewa, Burlingham, William, Sullivan, Jeremy, Djamali, Arjang, Pozniak, Myron, Yankol, Yucel, Fernandez, Luis A.

“…Delayed graft function (DGF) in renal transplant is associated with reduced graft survival and increased immunogenicity. The complement‐driven inflammatory…”
Get full text

Complement Blockade in Recipients Prevents Delayed Graft Function and Delays Antibody-mediated Rejection in a Nonhuman Primate Model of Kidney Transplantation by Eerhart, Michael J., Reyes, Jose A., Blanton, Casi L., Danobeitia, Juan S., Chlebeck, Peter J., Zitur, Laura J., Springer, Megan, Polyak, Erzsebet, Coonen, Jennifer, Capuano, Saverio, D’Alessandro, Anthony M., Torrealba, Jose, van Amersfoort, Edwin, Ponstein, Yolanda, van Kooten, Cees, Burlingham, William, Sullivan, Jeremy, Pozniak, Myron, Zhong, Weixiong, Yankol, Yucel, Fernandez, Luis A.

“…Complement activation in kidney transplantation is implicated in the pathogenesis of delayed graft function (DGF). This study evaluated the therapeutic…”
Get full text

Antithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients by Brokhof, Marissa M, Sollinger, Hans W, Hager, David R, Muth, Brenda L, Pirsch, John D, Fernandez, Luis A, Bellingham, Janet M, Mezrich, Joshua D, Foley, David P, D’Alessandro, Anthony M, Odorico, Jon S, Mohamed, Maha A, Vidyasagar, Vijay, Ellis, Thomas M, Kaufman, Dixon B, Djamali, Arjang

“…BACKGROUNDRecent evidence suggests that de novo donor-specific antibodies (dnDSA) are associated with antibody-mediated rejection (ABMR) and graft failure…”
Get full text

Brain Death Enhances Activation of the Innate Immune System and Leads to Reduced Renal Metabolic Gene Expression by Zitur, Laura J, Chlebeck, Peter J, Odorico, Scott K, Danobeitia, Juan S, Zens, Tiffany J, Van Kooten, Cees, Eerhart, Michael, Reyes, Jose A, Springer, Megan L, Coonen, Jennifer M, Brunner, Kevin G, Capuano, Saverio V, D’Alessandro, Anthony M, Fernandez, Luis A

“…BACKGROUND.Brain death (BD)–associated inflammation has been implicated in decreased kidney allograft function and survival, but the underlying mechanisms have…”
Get full text

Complications associated with liver transplantation in the obese recipient by LaMattina, John C., Foley, David P., Fernandez, Luis A., Pirsch, John D., Musat, Alexandru I., D'Alessandro, Anthony M., Mezrich, Joshua D.

“…The prevalence of the metabolic syndrome with attendant morbid obesity continues to increase nationwide. A concomitant increase in non‐alcoholic…”
Get full text

Lung transplantation with donation after cardiac death donors: Long-term follow-up in a single center by De Oliveira, Nilto C., MD, Osaki, Satoru, MD, PhD, Maloney, James D., MD, Meyer, Keith C., MD, Kohmoto, Takushi, MD, PhD, D'Alessandro, Anthony M., MD, Love, Robert B., MD

“…Objective We sought to examine long-term outcomes at the University of Wisconsin for all lung transplant recipients who received lungs from donation after…”
Get full text

Donation after cardiac death : The university of wisconsin experience with liver transplantation by FOLEY, David P, FERNANDEZ, Luis A, SOLLINGER, Hans W, KALAYOGLU, Munci, D'ALESSANDRO, Anthony M, LEVERSON, Glen, CHIN, L. Thomas, KRIEGER, Nancy, COOPER, Jeffery T, SHAMES, Brian D, BECKER, Yolanda T, ODORICO, Jon S, KNECHTLE, Stuart J

“…To determine whether the outcomes of liver transplantation (LTx) from donation after cardiac death (DCD) donors are equivalent to those from donation after…”
Get full text

Guidelines for the management of a brain death donor in the rhesus macaque: A translational transplant model by Zens, Tiffany J, Danobeitia, Juan S, Chlebeck, Peter J, Zitur, Laura J, Odorico, Scott, Brunner, Kevin, Coonen, Jennifer, Capuano, Saverio, D'Alessandro, Anthony M, Matkowskyj, Kristina, Zhong, Weixiong, Torrealba, Jose, Fernandez, Luis

“…The development of a translatable brain death animal model has significant potential to advance not only transplant research, but also the understanding of the…”
Get full text

Pretransplant donor‐specific anti‐HLA antibodies as predictors of early allograft rejection in ABO‐compatible liver transplantation by Musat, Alexandru I., Pigott, Courtney M., Ellis, Thomas M., Agni, Rashmi M., Leverson, Glen E., Powell, Amy J., Richards, Katelyn R., D'Alessandro, Anthony M., Lucey, Michael R.

“…The significance of preexisting donor‐specific HLA antibodies (HLA‐DSAs) for liver allograft function is unclear. Our previous studies have shown that humoral…”
Get full text

A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter by Yankol, Yücel, Bugeaud, Emily, Zens, Tiffany, Rizzari, Michael, Mecit, Nesimi, Leverson, Glen E, Foley, David, Mezrich, Joshua D, Kanmaz, Turan, Andaçoğlu, Oya Münevver, D'Alessandro, Anthony M, Acarlı, Koray Sadık, Kalayoğlu, Münci, Fernandez, Luis A

“…The progression of chronic kidney disease (CKD) in recipients of living-donor liver transplant (LDLT) compared to deceased-donor liver transplant (DDLT) has…”
Get full text

Understanding the antecedents of the acceptance of donation after cardiac death by healthcare professionals by D’Alessandro, Anthony M, Peltier, James W, Phelps, Joseph E

“…OBJECTIVE:A 3-yr study funded by the U.S. Department of Health and Human Services was conducted to identify potential barriers to and opportunities for…”
Get full text

Differential Outcomes of Expanded-Criteria Donor Renal Allografts According to Recipient Age by Mezrich, Joshua D, Pirsch, John D, Fernandez, Luis A, Foley, David P, Bellingham, Janet M, Odorico, Jon S, Leverson, Glen E, Munoz-Del-Rio, Alejandro, Sollinger, Hans W, Kaufman, Dixon B, D'Alessandro, Anthony M

“…Expanded-criteria donor (ECD) kidneys are used to expand the number of deceased-donor kidney transplants, often for elderly recipients. This study sought to…”
Get full text

Campath‐1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study by Knechtle, Stuart J., Pirsch, John D., H. Fechner, John, Becker, Bryan N., Friedl, Andreas, Colvin, Robert B., Lebeck, Lauralynn K., Chin, L. Thomas, Becker, Yolanda T., Odorico, Jon S., D'Alessandro, Anthony M., Kalayoglu, Munci, Hamawy, Majed M., Hu, Huaizhong, Bloom, Debra D., Sollinger, Hans W.

“…Campath‐1H, an anti‐CD52 monoclonal antibody, was used as induction therapy (40 mg i.v. total dose) in 29 primary human renal transplants, and the patients…”
Get full text

Alemtuzumab as compared to alternative contemporary induction regimens by LaMattina, John C, Mezrich, Joshua D, Hofmann, R Michael, Foley, David P, D'Alessandro, Anthony M, Sollinger, Hans W, Pirsch, John D

“…Between 1 January 2002 and 31 December 2007, our center performed 1687 adult renal transplants. A retrospective analysis was performed to compare outcomes…”
Get more information

Luminex-Based Desensitization Protocols: The University of Wisconsin Initial Experience by NIEDERHAUS, Silke V, MUTH, Brenda, LORENTZEN, David F, WAI, Philip, PIRSCH, John D, SAMANIEGO-PICOTA, Milagros, LEVERSON, Glen E, D'ALESSANDRO, Anthony M, SOLLINGER, Hans W, DJAMALI, Arjang

“…We have demonstrated that immunodominant donor-specific antibody (DSA) more than 100 mean fluorescence intensity (MFI) at the time of transplant is associated…”
Get full text

Outcomes of Simultaneous Liver/Kidney Transplants Are Equivalent to Kidney Transplant Alone: A Preliminary Report by HANISH, Steven I, SAMANIEGO, Milagros, MEZRICH, Joshua D, FOLEY, David P, LEVERSON, Glen E, LORENTZEN, David F, SOLLINGER, Hans W, PIRSCH, John D, D'ALESSANDRO, Anthony M, FERNANDEZ, Luis A

“…With adoption of Model for End-Stage Liver Disease, the number of simultaneous liver-kidney transplants (SLK) has greatly increased. A recent registry study…”
Get full text

Chronic Kidney Disease Stage Progression in Liver Transplant Recipients by Lamattina, John C, Foley, David P, Mezrich, Joshua D, Fernandez, Luis A, Vidyasagar, Vijay, D'Alessandro, Anthony M, Musat, Alexandru I, Samaniego-Picota, Milagros D, Pascual, Julio, Alejandro, Munoz D R, Leverson, Glen E, Pirsch, John D, Djamali, Arjang

“…There is little information on chronic kidney disease (CKD) stage progression rates and outcomes in liver transplant recipients. Identifying modifiable risk…”
Get full text

Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up by LaMattina, John C., Mezrich, Joshua D., Fernandez, Luis A., D'Alessandro, Anthony M., Djamali, Arjang, Musat, Alexandru I., Pirsch, John D., Foley, David P.

“…Introduction The incidence of chronic kidney disease (CKD) in liver transplant recipients has been estimated to be from 18% to 28% at 10 yr after…”
Get full text